Joint investor meeting with 2cureX on April 30

On April 30 Scandion Oncology and 2cureX hosted a joint investor arrangement at Symbion.

Sedermera (Denmark) was invited as moderator and presented their business model and track record.

A very positive investor meeting and lively discussion due to lots of good questions.

Thanks to all participants.

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union